QJBIOCH(SH:600796)2022-10-26 16:00Financial Performance - The company's operating revenue for Q3 2022 was approximately ¥464.96 million, a 4.00% increase compared to ¥447.07 million in the same period last year[6]. - Net profit attributable to shareholders for Q3 2022 reached ¥50.92 million, representing a significant increase of 34.21% from ¥37.94 million in the previous year[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥50.28 million, a remarkable increase of 988.51% compared to a loss of ¥5.66 million in the same period last year[9]. - The company reported a basic earnings per share of ¥0.14 for Q3 2022, compared to ¥0.06 in the same period last year, marking a 133.33% increase[7]. - The company’s net profit attributable to shareholders for the year-to-date period increased by 42.04% to ¥129.97 million from ¥91.50 million in the previous year[9]. - Net profit for the third quarter of 2022 was ¥121,892,457.90, up from ¥98,476,192.99 in the same quarter of 2021, reflecting a growth of approximately 23.93%[19]. - Earnings per share for the third quarter of 2022 were ¥0.15, compared to ¥0.14 in the same quarter of 2021, showing an increase of about 7.14%[20]. - The total comprehensive income for the third quarter of 2022 was ¥121,892,457.90, compared to ¥104,150,229.27 in the same quarter of 2021, indicating an increase of approximately 16.25%[20]. Cash Flow and Assets - The net cash flow from operating activities for the year-to-date period was ¥177.15 million, an increase of 85.67% compared to ¥95.41 million in the previous year[9]. - The company's cash and cash equivalents amounted to ¥986,788,855.42 as of September 30, 2022, an increase from ¥918,789,028.55 at the end of 2021[14]. - Total cash and cash equivalents at the end of the period reached CNY 951,721,774.50, up from CNY 510,294,771.71 at the end of the previous year[23]. - Cash received from operating activities totaled CNY 1,637,981,920.72, an increase from CNY 1,496,329,191.07 year-over-year[22]. - Cash received from sales of goods and services in the first three quarters of 2022 was ¥1,474,576,820.80, compared to ¥1,411,263,776.20 in 2021, marking an increase of approximately 4.48%[21]. - Cash paid for purchasing goods and services was CNY 1,007,992,406.06, slightly up from CNY 995,873,179.23 in the previous year[22]. Assets and Liabilities - Total assets at the end of the reporting period were approximately ¥6.60 billion, reflecting a 1.65% increase from ¥6.49 billion at the end of the previous year[7]. - The total liabilities as of the end of the third quarter of 2022 amounted to ¥3,252,145,844.12, compared to ¥3,186,065,352.21 at the end of 2021, representing an increase of approximately 2.07%[17]. - The total equity attributable to shareholders of the parent company was ¥2,936,311,914.23, up from ¥2,893,001,169.07 in the previous year, indicating a growth of about 1.49%[17]. - Total assets reached ¥6,596,915,985.61, up from ¥6,490,151,612.40 at the end of 2021[15]. - Accounts receivable decreased to ¥705,026,730.93 from ¥795,361,157.59 year-over-year[14]. - Inventory increased to ¥166,369,545.95 from ¥111,702,002.51 year-over-year[15]. - Short-term borrowings decreased significantly to ¥178,260,348.00 from ¥410,221,593.80[15]. Investments and Growth - The company completed a merger with Zhejiang Haiyun Environmental Protection Co., Ltd. in December 2021, which has been reflected in the financial statements[8]. - The company expects continued growth in its bioproducts segment, contributing to increased profitability in the upcoming quarters[9]. - The company has ongoing investments in new technologies and market expansion strategies, although specific figures were not disclosed in the report[13]. - Research and development expenses for the first three quarters of 2022 were ¥22,459,678.91, slightly down from ¥24,101,074.95 in 2021, reflecting a decrease of about 6.81%[18]. - The company reported investment income of ¥40,148,523.69 in the third quarter of 2022, a significant increase from ¥338,287.36 in the same quarter of 2021[19]. Shareholder Information - Total number of common shareholders at the end of the reporting period was 26,598[11]. - The largest shareholder, Haining Water Investment Group, holds 389,756,986 shares, representing 44.98% of total shares[11].